Pelthos Therapeutics Inc (PTHS) Stock Price, Quote, News & History

PTHSAMEX
$23.42
-1.13-4.6%
At close: Sep 9, 5:00 PM EST

Pelthos Therapeutics (PTHS) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-42.30M
Investing Cash Flow (TTM)
-5.43M
Financing Cash Flow (TTM)
72.23M
Free Cash Flow (TTM)
-50.49M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
24.50M

Analyst Trends and Forecast

2
Mar
1
Apr
1
May
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$142.91M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.86
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-116.62%
Earnings Yield % (FWD)
-19.45%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.39

Company Debt

Total Debt
$69.91M
LT Debt
$69.91M
LT Debt Issuance (TTM)
$47.24M
LT Debt Repayment (TTM)
-
Total Cash
$24.19M
Debt to Equity
-
Issuance of Debt (TTM)
$45.42M
Repayment of Debt (TTM)
-$2.66M

Key Statistics

Open
$24.26
Close
$23.42
Volume / Avg.
27.49K / 56.95K
Day Range
$23.26 - $24.99
52 Wk Range
18.19 - 37.50
Market Cap
$93.99M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
38
Short Interest
4.67%
Days to Cover
1.16

About

Sector
Health Care
Industry
Biotechnology
Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens. The Company currently has three U.S. Food and Drug Administration (FDA) appr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Pelthos Therapeutics (PTHS) stock?

A

You can purchase shares of Pelthos Therapeutics (AMEX:PTHS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pelthos Therapeutics (PTHS) competitors?

Q

What is the forecast, or price target, for Pelthos Therapeutics (PTHS) stock?

A

Pelthos Therapeutics has a consensus price target of $54.50.

Q

What is the current price for Pelthos Therapeutics (PTHS)?

A

The stock price for Pelthos Therapeutics (AMEX: PTHS) is $ last updated .

Q

Does Pelthos Therapeutics (PTHS) pay a dividend?

A

There are no upcoming dividends for Pelthos Therapeutics.

Q

When is Pelthos Therapeutics (AMEX:PTHS) reporting earnings?

A

Pelthos Therapeutics does not have any upcoming earnings scheduled.

Q

Is Pelthos Therapeutics (PTHS) going to split?

A

There is no upcoming split for Pelthos Therapeutics.

Q

What sector and industry does Pelthos Therapeutics (PTHS) operate in?

A

Pelthos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.